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Table 1. Comparison Between the Results of Our Study 
and Those of Yee et al.
Yee et al.
O ur study: 
No sedation 
or GA
Alfentanil
(20 jag/ Methohexital 
kg) (0.5 m g/kg)
n 15 15 15
Male:female 5:10 8:7 8:7
Mean age (yr) 69.60 ± 10.60" 66 ± 7 66 ± 7
Movement score during 15 X 0 12 X 0 1 X 0
RBB 3 X 1 12 X 1
2 X 2
Ventilatory depression
score
15 X 0 12 X () 12 X 0
2 X 1 3 X 1
1 X 2
Nausea (%) 0 7 13
Response to verbal 100 87 0
commands (%)
Recall (%) 100 80 20
Apnea (%) 0 6.67 0
Time to discharge (min) Immediately 45 ± 15 43 ± 20
VAS for pain during 0 b —
surgery
VAS for pain during 0.47 ± 0.64" 0 —
RBB
VAS for discomfort 14 X 0 0 --,
during RBB 1 X 1
placement of a retrobulbar and facial nerve block without any 
sedation or analgesia, we believe it would be difficult to convince 
most patients and their surgeons to forego any sedation during this 
procedure. Furthermore, we believe that with adequate monitoring 
and vigilance patients can be safely sedated using the technique 
described in our paper (3) or other well-documented methods for 
this and other similar procedures.
James B. Yee, m d , PhD
Department of Anesthesiology 
University of Utah School of Medicine 
Salt Lake City, I IT 84132
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GA ~ general anaesthesia; RBB 
scale (0 - 10),
1 Data are mean ± s d .  
h Not reported by Yee et a l
retrobulbar block; VAS = visual analog
they would find increasing improvement of their data as the dosage 
of alfentanil approaches zero. Is it really necessary to administer 
potentially dangerous analgesics or sedative hypnotics to these 
elderly people for pain reported to be equal to or less than the pain 
and discomfort experienced during placement of an IV cannula?
André P. Boezaart, ffa(SA)
Louis C. Boezaart, MMed(Ophth)
Roland Berry, MMod(Opiuh)
University of Stellenbosch 
Cape Town, South Africa
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Pain on Injection of Rocuronium Bromide
To the Editor:
We read with interest the letter of Moor thy and Dierdorf (1) about 
pain on injection of rocuronium. With subparalyzing doses, they 
noticed that "most" patients had "severe burning pain" on injection 
of the rocuronium.
We have noted in 105 consecutive patients requiring subparalyz- 
ing rocuronium the indicence of pain on injection of the rocuro­
nium. The site of injection, the age and sex of the patients, and the 
degree of pain (mild, moderate, severe) were also noted. Using x2 
tests, the relation between site of injection and pain and between the 
sex of the patient and the pain were analyzed. No relationship was 
seen between site of injection or sex of the patient and the pain on 
injection. Fifty-two patients of the 105 had pain on injection of 
rocuronium. Of these 52 patients, 13 (12%) patients had what they 
described as severe pain.
These results suggest that rocuronium is not suitable for use as a 
subparalyzing dose before succinylcholine or in priming. Priming 
has also been shown to be of little value (2,3) in speeding the onset 
time of rocuronium. The patient should probably be asleep before 
rocuronium is administered to the patient.
M. A. H. Steegers, m d  
E. N. Robertson, f r c a
Department of Anesthesiology 
Academisch Ziekenhuis Nijmegen 
Nijmegen, The Netherlands
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In Response:
We wish to thank Drs. Boezaart, Boezaart, and Berry for their letter 
suggesting that no sedation or analgesia is needed for the placement 
of retrobulbar nerve block. However, there are a few points that 
must be considered before applying these findings lo this patient 
population in general. Previous reports have found that patients 
often openly express anxiety about the placement of this block (1) 
and that there is an increased anxiety score in nonmedicaled pa­
tients undergoing ophthalmic surgery (2). We have also found this 
to be the case, with patients often voicing concern about receiving a quality of care and reduced cost uses cost-effectiveness modeling to 
"shot behind the eye" and requesting to be "asleep" during this part conclude that improving quality of perioperative care may be cost-
Cost-Effective Modeling
To the Editor:
Drs. Dexter and Tinker's examination of the relationship between
of their procedure. Second, it is well known that patients who are 
"too light" or not adequately sedated will move or wince in re­
sponse to the local anesthetic injection for the retrobulbar and/or 
facial nerve block. This would indicate that there is a significant
effective only for high-risk operations (1). Although this theoretical 
approach to cost containment provides many insights, it is impor­
tant to acknowledge the study's limited perspective.
The investigations, while focused on cost minimization for hos-
amount of painful stimulation being perceived by the patient. Fur- pital care, have taken the perspective of the payer. Currently, there 
thermore, we have completed a study (which is in press) examining is increasing recognition of the importance of other perspectives, 
the dose response of alfentanil on movement during block place- including care provider, hospital, patient, and society. Further study
ment. We noted that, in general, lower doses of alfentanil result in is needed to establish the proper role of these various perspectives
more movement by the patients. While we have not attempted the in cost-effectiveness studies. For example, from the perspective of
